Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04793295 · ClinicalTrials.gov registry record · Phase 1
Study to Investigate Drug-Drug Interaction Between MT-7117 and Test Drugs in Healthy Subjects
A Phase 1 study, sponsored by Tanabe Pharma America.
- Completed
- Registry status
- Phase 1
- Development phase
- 112
- Enrollment target
NCT04793295: Completed Phase 1 study, sponsored by Tanabe Pharma America.
NCT04793295 is a Phase 1 study that has completed, run by Tanabe Pharma America. The registered enrollment target is 112 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (87% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04793295, a Phase 1 study, has completed, sponsored by Tanabe Pharma America.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 112 participants
- Enrollment target
Study Summary
Study is to investigate drug levels in the blood after taking single or multiple doses of the study drug, MT-7117, in healthy adults when taken together with another drug. This study will also look at the safety and the body's ability to tolerate MT-7117
Primary Outcome
PK parameters of IMP Test Products in the absence and presence of MT-7117 (Parts 1, 2, and 3) and MT-7117 in the absence and presence of test drug 7 (Part 4)
Interventions
- DRUG MT-7117
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 112 participants |
| Start Date | 2021-03-23 |
| Est. Completion | 2022-02-04 |
| Phase | Phase 1 |
What the finished NCT04793295 record still lists
NCT04793295 is an interventional study that assigns participants to a tested intervention. The registered 112 participants enrollment target is mid-sized for trials with a published cap, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (87% higher).
The record links to 0 conditions, and to 1 intervention - of which MT-7117 is the first listed.
NCT04793295 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04793295 about?
NCT04793295 is a clinical study titled "Study to Investigate Drug-Drug Interaction Between MT-7117 and Test Drugs in Healthy Subjects". Study is to investigate drug levels in the blood after taking single or multiple doses of the study drug, MT-7117, in healthy adults when taken together with another drug. This study will also look at the safety and the body's ability to tolerate MT-7117
What is the current status of trial NCT04793295?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 112 participants. The study started on 2021-03-23. Estimated completion is 2022-02-04.
What interventions are being tested in trial NCT04793295?
The interventions under investigation include: MT-7117 (DRUG).
Who is sponsoring clinical trial NCT04793295?
This trial is sponsored by Tanabe Pharma America, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04793295's enrollment target sits among peer trials
112 508th of 2000 higher than 1,489 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04511013 · 112 participants · Phase 2
A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
- NCT04551560 · 112 participants · NA
Stress and Congestive Heart Failure
- NCT04872166 · 112 participants · Phase 1
A Study of BTX-A51 in People With Advanced Solid Tumor and Breast Cancer
- NCT05024773 · 112 participants · Phase 3
Study of ONCOFID-P-B (PACLITAXEL-HYALURONIC ACID)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI